Chemicals and Stock Solutions. C13 and C12 mono-ester phthalate monomethyl phthalate (MMP), monoethyl phthalate (MEP), monobutyl phthalate (MBP), mono-2ethylhexyl phthalate (MEHP), monobenzyl phthalate (MBzP), mono-2-ethyl-5hydroxyhexyl phthalate (MEHHP), mono-2-ethyl-5-carboxypentyl (MECPP) and mono-2-ethyl-5-oxohexyl phthalate (MEOHP) were purchased from CIL (Cambridge Isotope Laboratory Ins, USA). The steroid hormone standards of androstenedione (ASD) and testosterone were purchased from Dr. Ehrenstorfer GmbH (Germany), the isotope D3-testosterone was purchased from Cerilliant (Promochem, Wesel, Germany). Escherichia coli β-glucuronididase was purchased from Sigma-Aldrich, USA. Oasis HLB solid phase extraction (SPE) cartridges (60 mg, 3 mL, Waters, USA) were purchased from Waters Corporation (Milford, MA). All other chemicals were analytical grade.
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SPE Purification. The column was preconditioned with acetonitrile (3 mL) and phosphate buffer (3 mL, pH = 2, 0.14 M NaH2PO4 in 0.85% H3PO4) in sequence. The treated urine was loaded onto the cartridge at a rate of 1 mL/min. Then it was rinsed with 0.1 M formic acid (2 mL) and H2O (1 mL) and dried with a gentle airflow. The analytes were eluted with acetonitrile (3 mL) followed by ethyl acetate (2 mL) at 1 mL/min. The eluate was evaporated to dryness under a gentle stream of nitrogen at 45 o C and the dried residue was re-suspended in 200 µL of 60% acetonitrile (0.1% acetic acid) until further analysis.
HPLC-ESI-MS/MS analysis.
The target compounds were separated by the LC-20A prominence (Shimadzu, Kyoto, Japan) high-performance liquid chromatography (HPLC) equipped with the Phenomenex® (Torrance, CA, USA) guard column (Phenyl, 4.0 mm × 2.0 mm internal diameter) and separation column (Luna Phenyl-hexyl, 100 mm×2.0 mm internal diameter, 3.0 µm particle size). Mobile phase A was 0.1% acetic acid in water and B was 0.1% acetic acid in acetonitrile. Table S1 shows the HPLC gradient program. The mobile phase flow rate was set at 0.25 mL/min, and the column temperature was set at 30 o C. The total run time for each injection was 20 min and the injection volume was 20 µL.
The target compounds were ionized by electrospray ionization (ESI) and detected by the tandem mass spectrometry (MS/MS) (Applied Biosystems, Concord, Ontario, Canada). The mass specific detection was achieved using a MDS Sciex 3200 Q TRAP triple quadrupole linear ion trap mass spectrometer equipped with a TurboIonSpray ESI source and Analyst Software version 1.5 (Applied Biosystems, Concord, Ontario, S4 Canada). ESI-MS/MS was performed at unit mass resolution in multiple reaction monitoring (MRM) under the negative ion mode with the following parameters: source temperature (TEM) 550 o C, ion spray voltage (IS) -4500 V, curtain gas (CUR) 10 psi (46 kPa of nitrogen), ion source gas 1 (GS1) 40 psi (276 kPa of nitrogen), ion source gas 2 (GS2) 40 psi (276 kPa of nitrogen), collision gas pressure (nitrogen) medium [corresponds to value of 3 (arbitrary scale of 1-12)], and dwell time of 50 ms per channel. Optimization of the compound-dependent MS/MS parameters was performed with phthalate metabolites standards via direct injection into the mass spectrometer using a syringe pump at a flow rate of 10 µL/min. Optimal settings for compounddependent MS/MS parameters are shown in Table S2 .
The Absolute Recovery of SPE Extraction. The phthalate metabolite's standard curve regression equation and absolute recoveries during SPE extraction were calculated (Table S3 and S4). Considering the background analytes in the urine, we used the labeled internal standard to track the SPE recovery instead of the native compounds.
One of the paired spiking samples was added the labeled internal standards before SPE (Concbefore); the other was added the labeled internal standards after SPE (Concafter).
The SPE recovery was calculated as: SPE recovery = (Concafter/Concbefore)  100%.
Because of the recoveries in the urine expression step are close to hundred percent for the analytes, the absolute recoveries of the whole sample preparation procedure should be comparable with the reported SPE extraction recoveries for adult urine analysis 1 . In case of the low SPE recovery, the stable isotope-labeled compounds as internal standards had been used to correct the possible matrix effects and to improve method S5 accuracy and precision. 
Introduction
The concept of integrating human observations with laboratory tests comes from the facts both human study and laboratory test can address the metabolic phenotypes in blood and urine or in biotas of in vitro or in vivo. The hypothesis is environmental stimulation induced any effect will finally translate to metabolic layer change.
Therefore, to march the metabolite alteration in human with the metabolic effect in toxicological model would improve the communication between the two disciplines ( Figure S3 ) herein. set of experiments were set to verify the dose-dependent effect of DBP. MLTC-1 cells were exposed to either DMSO vehicle control or DBP at 5, 10, 25, 50 or 100 μM. After 48-h phthalate treatment, the culture medium was collected for phthalate metabolites S14 analysis, the cells were washed with PBS and serum-free medium. After these steps, the cells were further stimulated with hCG for 4 h in serum-free medium with 0.1% BSA, then this medium was collected for ASD and testosterone determination.
PAE metabolites and steroid hormones measurements in cell culture medium
Phthalate metabolites and steroid hormones in cell culture medium were detected using LC-ESI-MS/MS following the protocol like in urine sample, which have be described in SI-1. Asterisks (**) indicate the significant differences (p <0.001) between the present (positive) and absent (negative) of esterase in the culture medium.
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RESULTS
PAEs exposure range and Leydig cell viability
Biphasic steroidogenic effect profiles of PAEs in Leydig cells
Because DBP may have more toxic characteristics than other PAEs 4 , its steroidogenic effects on ASD and testosterone generation were initially profiled in detail from 5 to 100 μM (Figure S6 Figure S6 B) . In the 10-μM treatment groups, no effect on testosterone production is observed for all the investigated chemicals. This suggests that ASD regulation may be a more sensitive biomarker than testosterone in response to low-level treatment of PAEs.
In the 100-μM groups, DEP acts as a stimulator of testosterone generation (FC = 1.19; p = 0.001), while DBzP significantly inhibits production of testosterone (FC = 0.64; p < 0.001) but to a lesser extent than DBP (FC = 0.09, p < 0.001); DEHP also markedly (not significant) inhibits testosterone production (FC = 0.90; p = 0.12) (Figure S6 B, E). 
Steroidogenic responses to PAE mixture exposures in Leydig cells
Both monoester and diester PAEs mixture tests may simulate some scenarios of real-world human exposure. Firstly, exposed PAEs can rapidly undergo liver metabolism in humans and monoesters are the major functional forms. In relation to S22 ASD secretion, when compared with the control group, the entire monoester dose range (from 0.1 to 100 μM mixture) significantly stimulated ASD production, while testosterone stimulation only begins to be significant from the ≥10-μM mixture but begins to be attenuated at the 100-μM mixture ( Figure S6 C and F) . When the exogenous esterase was added in the diester mixture, the diester inhibitory effect is totally reversed for ASD and testosterone production ( Figure S6 C and F) . This further supports the notion that monoester residuals may have a very limited possibility to act as anti-androgens in real-world human exposure scenarios.
Although each individual diester (except DBP) at 100 μM only exhibits androgenic effects, their mixtures may replicate an extremely high human exposure scenario, wherein both ASD and/or testosterone secretion are inhibited in MLTC-1 model. However, the data from exogenous esterase addition may support the notion that human metabolism can mitigate or reverse anti-androgenic effects to androgenic. The low-dose (at least 10 μM) diester exposure suggests that some minimal PAEs exposure scenarios still generate androgenic effects. The data also suggests that generally, diester forms more readily act as anti-androgens than monoesters. Because of the much lower detection frequency of MBzP (BBzP can also be the hydrolysed to MBzP) in our participant urine implied a much lower-level DBzP exposure, the MLTC-1 cells results factually support the present observations that PAEs exposure can readily transition from androgenic to anti-androgenic mechanism of action.
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